Literature DB >> 10657631

Regulator of G protein signaling 1 (RGS1) markedly impairs Gi alpha signaling responses of B lymphocytes.

C Moratz1, V H Kang, K M Druey, C S Shi, A Scheschonka, P M Murphy, T Kozasa, J H Kehrl.   

Abstract

Regulator of G protein signaling (RGS) proteins modulate signaling through pathways that use heterotrimeric G proteins as transducing elements. RGS1 is expressed at high levels in certain B cell lines and can be induced in normal B cells by treatment with TNF-alpha. To determine the signaling pathways that RGS1 may regulate, we examined the specificity of RGS1 for various G alpha subunits and assessed its effect on chemokine signaling. G protein binding and GTPase assays revealed that RGS1 is a Gi alpha and Gq alpha GTPase-activating protein and a potential G12 alpha effector antagonist. Functional studies demonstrated that RGS1 impairs platelet activating factor-mediated increases in intracellular Ca+2, stromal-derived factor-1-induced cell migration, and the induction of downstream signaling by a constitutively active form of G12 alpha. Furthermore, germinal center B lymphocytes, which are refractory to stromal-derived factor-1-triggered migration, express high levels of RGS1. These results indicate that RGS proteins can profoundly effect the directed migration of lymphoid cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10657631     DOI: 10.4049/jimmunol.164.4.1829

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

1.  RGS18 is a myeloerythroid lineage-specific regulator of G-protein-signalling molecule highly expressed in megakaryocytes.

Authors:  D Yowe; N Weich; M Prabhudas; L Poisson; P Errada; R Kapeller; K Yu; L Faron; M Shen; J Cleary; T M Wilkie; C Gutierrez-Ramos; M R Hodge
Journal:  Biochem J       Date:  2001-10-01       Impact factor: 3.857

2.  Abnormal B-cell responses to chemokines, disturbed plasma cell localization, and distorted immune tissue architecture in Rgs1-/- mice.

Authors:  Chantal Moratz; J Russell Hayman; Hua Gu; John H Kehrl
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

Review 3.  Role of G12 proteins in oncogenesis and metastasis.

Authors:  Juhi Juneja; Patrick J Casey
Journal:  Br J Pharmacol       Date:  2009-04-30       Impact factor: 8.739

4.  DNA microarray gene expression profile of marginal zone versus follicular B cells and idiotype positive marginal zone B cells before and after immunization with Streptococcus pneumoniae.

Authors:  Nicholas W Kin; Dianna M Crawford; Jiabin Liu; Timothy W Behrens; John F Kearney
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

Review 5.  Therapeutic approaches for celiac disease.

Authors:  Nicholas M Plugis; Chaitan Khosla
Journal:  Best Pract Res Clin Gastroenterol       Date:  2015-05-09       Impact factor: 3.043

6.  An integrative genomic analysis of the superior fecundity phenotype in QSi5 mice.

Authors:  Jerry Wei; Palaniappan Ramanathan; Peter C Thomson; Ian C Martin; Christopher Moran; Peter Williamson
Journal:  Mol Biotechnol       Date:  2013-02       Impact factor: 2.695

7.  Regulation of Chemokine Signal Integration by Activator of G-Protein Signaling 4 (AGS4).

Authors:  William G Robichaux; Melissa Branham-O'Connor; Il-Young Hwang; Ali Vural; Johne H Kehrl; Joe B Blumer
Journal:  J Pharmacol Exp Ther       Date:  2017-01-06       Impact factor: 4.030

8.  Genetic association between RGS1 and internalizing disorders.

Authors:  John M Hettema; Seon-Sook An; Edwin J C G van den Oord; Michael C Neale; Kenneth S Kendler; Xiangning Chen
Journal:  Psychiatr Genet       Date:  2013-04       Impact factor: 2.458

9.  Variations in Gnai2 and Rgs1 expression affect chemokine receptor signaling and the organization of secondary lymphoid organs.

Authors:  I Y Hwang; C Park; K A Harrision; N N Huang; J H Kehrl
Journal:  Genes Immun       Date:  2010-05-27       Impact factor: 2.676

10.  Marginal zone precursor B cells as cellular agents for type I IFN-promoted antigen transport in autoimmunity.

Authors:  John H Wang; Jun Li; Qi Wu; PingAr Yang; Rahul D Pawar; Shutao Xie; Laura Timares; Chander Raman; David D Chaplin; Lu Lu; John D Mountz; Hui-Chen Hsu
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.